Dermatology · San Francisco, CA
NPI
1750561056
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
995 Potrero Avenue, Bldg 90, Ward 92
San Francisco, CA, 94110
Phone (628) 206-8680
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
1,235 services
Medicare patients, 2024
189
Average age 71
Drug cost, 2024
$2.2M
772 prescriptions
Company payments, 2024
$8,316
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Haley Naik was code 17003 (destruction skin lesion), 277 times for 42 patients. In total Haley Naik billed 1,235 services in 37 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 277 | 42 | $1.72 | $476 |
| 99214 Office E&M - Established | Office | 129 | 93 | $75.61 | $9,753 |
| 17000 Destruction Skin Lesion | Office | 91 | 59 | $43.21 | $3,932 |
| 99213 Office E&M - Established | Office | 88 | 72 | $51.26 | $4,511 |
| 17110 Destruction Skin Lesion | Office | 42 | 36 | $60.77 | $2,552 |
| 99204 Office E&M - New | Office | 32 | 32 | $96.90 | $3,101 |
| 11102 Skin Biopsy | Office | 29 | 28 | $20.48 | $594 |
| 99203 Office E&M - New | Office | 20 | 20 | $61.88 | $1,238 |
By year: 2022 $28K for 586 services; 2023 $27K for 560 services; 2024 $41K for 1,235 services.
Medicare prescription drug claims, 2024
In 2024, the drug Haley Naik prescribed most often to Medicare patients was Remicade (Infliximab), with 60 prescriptions and refills. In total Haley Naik wrote 772 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Remicade Infliximab | 60 | 60 | Under 11 | $655K |
| Methotrexate Methotrexate Sodium | 49 | 70 | Under 11 | $946 |
| Triamcinolone Acetonide Generic | 44 | 53 | 33 | $529 |
| Fluocinonide Generic | 39 | 43 | 19 | $1,587 |
| Ketoconazole Generic | 39 | 41 | 14 | $579 |
| Sodium Chloride 0.9 % Sodium Chloride | 32 | 32 | Under 11 | $66.89 |
| Cosentyx Unoready Pen Secukinumab | 26 | 27 | Under 11 | $340K |
| Clindamycin Phosphate Generic | 25 | 30 | Under 11 | $679 |
| Humira(Cf) Pen Adalimumab | 24 | 24 | Under 11 | $493K |
| Hydroxychloroquine Sulfate Generic | 24 | 26 | Under 11 | $569 |
| Doxycycline Hyclate Generic | 24 | 28 | Under 11 | $319 |
| Minoxidil Generic | 23 | 51 | Under 11 | $462 |
| Dupixent Pen Dupilumab | 23 | 24 | Under 11 | $95K |
| Cosentyx Sensoready (2 Pens) Secukinumab | 22 | 27 | Under 11 | $280K |
| Clobetasol Propionate Generic | 22 | 23 | 15 | $1,351 |
Brand drugs: 258 claims; generic drugs: 514 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Haley Naik $8,316 ($8,316 in general payments such as food, travel and fees) from 3 companies. The largest payer was UCB, Inc. with $4,500.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.